Meningococcal group B vaccine (Trumenba) to prevent more types of invasive 
meningococcal disease; antihemophilic factor (recombinant), porcine sequence 
(Obizur) to treat bleeding from acquired hemophilia A; and pirfenidone (Esbriet) 
and nintedanib (Ofev) for idiopathic pulmonary fibrosis.